<DOC>
	<DOC>NCT02587364</DOC>
	<brief_summary>The purpose of this study is to evaluate the multiple‐dose pharmacokinetic characteristics and pharmacologic activity of gemcabene.</brief_summary>
	<brief_title>Pharmacokinetics and Pharmacodynamics Study of Gemcabene in Healthy Volunteers</brief_title>
	<detailed_description />
	<mesh_term>Hypercholesterolemia</mesh_term>
	<criteria>Good health as determined by medical history, physical examination, electrocardiogram (ECG), vital signs, and laboratory assessments Body weight: 60‐100 kg (desirable) Use of any medication not considered acceptable by the clinical investigators during the 14‐day period before the start of the study (Day 1) ; Donation of a unit of blood or participation in a study of investigational or marketed drugs during the 30‐day period before the start of the study (Day 1); If female, of childbearing potential or lactating; History of significant reaction to any fibrate lipid‐lowering agent; and Significant urine collection of any drug which could interfere with the study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>October 2015</verification_date>
	<keyword>Pharmacokinetics</keyword>
	<keyword>Lipid Regulator</keyword>
</DOC>